BamSEC and AlphaSense Join Forces
Learn More

Insmed Incorporated – Material Contracts

NASDAQ: INSM    
Share price (5/22/26): $106.24    
Market cap (5/22/26): $23.0 billion

Material Contracts Filter

EX-10.25 1
from 10-K 2 pages Amendment 1 to Product Agreement for Brensocatib Film Coated Tablets (10mg and 25mg) and Bottling Between Patheon Inc. and Insmed Incorporated
12/34/56
EX-10.4 6
from 10-K 15 pages Insmed Incorporated Non-Qualified Stock Option Agreement Under the 2025 Inducement Plan for NON-U.S. Participants
12/34/56
EX-10.4 5
from 10-K 6 pages Insmed Incorporated Non-Qualified Stock Option Agreement Under the 2025 Inducement Plan for U.S. Participants
12/34/56
EX-10.3 11
from 10-K 10 pages Insmed Incorporated Performance-Based Restricted Stock Unit Award Agreement Under the Amended and Restated 2019 Incentive Plan for NON-U.S. Grantees
12/34/56
EX-10.3 10
from 10-K 8 pages Insmed Incorporated Performance-Based Restricted Stock Unit Award Agreement Under the Amended and Restated 2019 Incentive Plan for U.S. Grantees
12/34/56
EX-10.3 9
from 10-K 14 pages Insmed Incorporated Non-Qualified Stock Option Agreement Under the Amended and Restated 2019 Incentive Plan for NON-U.S. Participants
12/34/56
EX-10.3 8
from 10-K 7 pages Insmed Incorporated Non-Qualified Stock Option Agreement Under the Amended and Restated 2019 Incentive Plan for U.S. Participants
12/34/56
EX-10.1
from 10-Q 8 pages First Amendment
12/34/56
EX-10.1
from 10-Q 8 pages Material contract
12/34/56
EX-10.5
from 10-Q 14 pages Insmed Incorporated Non-Qualified Stock Option Agreement Under the 2025 Inducement Plan for NON-U.S. Participants
12/34/56
EX-10.4
from 10-Q 5 pages Insmed Incorporated Non-Qualified Stock Option Agreement Under the 2025 Inducement Plan for U.S. Participants
12/34/56
EX-10.3
from 10-Q 11 pages Insmed Incorporated Restricted Stock Unit Award Agreement Under the 2025 Inducement Plan for NON-U.S. Grantees
12/34/56
EX-10.2
from 10-Q 8 pages Insmed Incorporated Restricted Stock Unit Award Agreement Under the 2025 Inducement Plan for U.S. Grantees
12/34/56
EX-10.27
from 10-K 36 pages Commercial Manufacturing and Supply Agreement
12/34/56
EX-10.25 1
from 10-K 102 pages First Amendment to Revenue Interest Purchase Agreement
12/34/56
EX-10.24 1
from 10-K 11 pages Product Agreement Product Agreement for Brensocatib Film Coated Tablets (10mg and 25mg) and Bottling
12/34/56
EX-10.24
from 10-K 54 pages Master Commercial Manufacturing Services Agreement
12/34/56
EX-10.19 2
from 10-K 2 pages Amendment No. 2 to Commercialization Agreement Between Insmed Incorporated and Pari Pharma Gmbh
12/34/56
EX-10.5 1
from 10-Q 5 pages Amendment No. 1 to Commercialization Agreement Between Insmed Incorporated and Pari Pharma Gmbh
12/34/56
EX-10.5
from 10-Q 57 pages Commercialization Agreement
12/34/56